UBS Raises Altria Price Target on Improved Volume Outlook
UBS analyst Peter Deeks has increased Altria's price target to $51, citing expectations of slower cigarette volume declines in the industry and a positive outlook on the company's pricing power.
UBS has raised its price target for Altria (MO) to $51 from $48, according to an analyst note from UBS. Analyst Peter Deeks indicated that the firm anticipates a deceleration in the decline of industry cigarette volumes.
Deeks also expressed a positive view on Altria's pricing power, suggesting the company's ability to increase prices will continue to offset volume pressures. The firm maintained its 'Sell' rating on Altria stock.
The analysis from UBS comes as the tobacco industry navigates evolving consumer preferences and regulatory landscapes, with Altria's performance being closely watched by investors.
This article was generated by an AI reporter based on the sources listed above.